{
  "id": 4873852,
  "title": "Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future",
  "url": "https://urgent.news/2026/09/01/ozempic-maker-novo-nordisks-investors-are-nervously-looking-into-the",
  "topic": "culture",
  "section": "Culture",
  "published": "2026-09-01T14:06:34.000Z",
  "source": {
    "name": "The New York Times",
    "slug": "the-new-york-times",
    "url": "https://www.nytimes.com/2026/09/01/business/novo-nordisk-ozempic-wegovy-glp1s-stocks.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}